Privia Health Group, Inc. provided revenue guidance for the fiscal year 2022. GAAP revenue to be $1,225 million to $1,300 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.15 USD | -1.94% | -1.27% | -25.53% |
05-30 | Baird Starts Privia Health Group With Outperform Rating, $23 Price Target | MT |
05-20 | Barclays Adjusts Price Target on Privia Health to $19 From $22, Maintains Equalweight Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.53% | 2.05B | |
+24.66% | 88.38B | |
-21.76% | 77.56B | |
+1.76% | 26.97B | |
+7.94% | 18.45B | |
-13.50% | 16.57B | |
+3.23% | 15.81B | |
+77.51% | 13.65B | |
+76.96% | 13.06B | |
+23.02% | 12.55B |
- Stock Market
- Equities
- PRVA Stock
- News Privia Health Group, Inc.
- Privia Health Group, Inc. Provides Revenue Guidance for the Fiscal Year 2022